Krsnaa Diagnostics has filed draft papers with capital markets,
Sebi to elevate finances via an preliminary proportion sale. The IPO contains clean problem of fairness stocks really well worth Rupees. four hundred crore and a suggestion for sale (OFS) of as much as 94,16,377 stocks through its current shareholders, consistent with the draft crimson herring prospectus (DRHP).
Those providing stocks withinside the OFS are Phi
Capital, Kitara, Somerset Indus Healthcare Fund I Ltd and Lotus Management
Solutions. The organisation, in session with its service provider bankers, can
also additionally take into account to elevate Rs 2 hundred crore withinside
the pre-IPO placement. Proceeds from the clean problem can be used for
financing the price of setting up diagnostics centres at Punjab, Karnataka,
Himachal Pradesh, and Maharashtra; compensation of loans availed through the
organisation and widespread company purposes.
Krsnaa
Diagnostics offers quite a number technology-enabled diagnostic offerings which
include imaging (inclusive of radiology), pathology/scientific laboratory and
tele-radiology offerings to public and personal hospitals, clinical schools and
network fitness centres pan-India.
The organization specializes in the general public personal partnership (PPP)
diagnostics segment, and has the biggest presence withinside the diagnostic PPP
segment. As of December 2020, the organization operated 1,801 diagnostic
centres presenting each radiology and pathology offerings in thirteen states
throughout the country. JM Financial, DAM Capital Advisor, Enquires Capital,
and IIFL Securities were appointed as service provider bankers to advocate the
organization at the IPO.
Corporate Office: Krsnaa Diagnostics Ltd, S No,243-A, Plot No-6/6, Near Mayur Trade Centre PimpriChinwad Pune-411019-INDIA